Overview
Location
Canada, Ontario, Toronto
Mentions in press and media 20
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 23, 2022 | PRESS RELEASE | ADEQ Announces $25 Million Investment to Improve PFAS Treatment at Tucson Water Treatment Plant | PHOENIX (Dec. 23, 2022) — Arizona Department of Environmental Quality today announced $25 million in funding to help Tucson Water improve per- and polyfluoroalkyl substances (PFAS) treatment at a Tucson Water treatment plant addressing seve... |
| Sep 2, 2021 | American Treatment Network Raises $5.3 Million in Oversubscribed Series A | HAVERTOWN, Pa. (PRWEB) September 02, 2021 American Treatment Network announced today the closing of its Series A fundraising round. Proceeds will be used to enter the state of Delaware with locations in New Castle, Kent, and Sussex Counties... |
| Mar 16, 2021 | Foundation for Opioid Response Efforts (FORE) Announces Grants Totaling $1.3 Million to Assess Impact of COVID-19 on Opioid Use Disorder Treatment and Equity | |
| Jan 23, 2019 | Dog cancer treatment startup raises $5 million from Andreessen Horowitz and others | One in every three dogs gets cancer, according to the National Canine Cancer Foundation. The One Health Company, a startup that just raised a $5 million seed round led by Andreessen Horowitz’s Bio fund with participation from Lerer Hippeau ... |
| Feb 28, 2018 | Conjunctivitis treatment gets $13m from Brandon Capital for local trial | Australians with viral conjunctivitis will be the first to try drops that hope to clear up the eye infection and reduce its fortnight-long infectious period, after an opthalmic drug developer was lured from San Diego to Sydney by $13 millio... |
| Aug 27, 2014 | AbGenomics developing monoclonal antibody-based psoriasis treatment, raises $13.6M | The psoriasis treatment, AbGn-168H, can specifically target late-stage activated T-cells to treat immune disorders that stretch beyond the skin condition, AbGenomics said. It can extend to Type I diabetes, multiple sclerosis and Crohn’s dis... |
| Jul 12, 2012 | Biotech with Lysosomal storage disorder treatment raising $3.5 million, doubles staff | Hung Do, the chief science officer of Callidus Biopharma, based at the Pennsylvania Biotechnology Center in Doylestown, Pennsylvania, told MedCity News that he believes the enzyme replacement therapies currently on the market are inefficien... |
| Apr 30, 2012 | Catheter infection treatment firm raises $750K, seeks $2M to market product | Now the company is eyeing a $2 million series A round. That money will be used to win regulatory clearance and have a limited launch of its ClearGuard technology, whose first application will target hemodialysis patients prone to catheter-r... |
| Mar 2, 2012 | New sleep disorder treatment biotech raising $2.75M | Listed in a recent filing with the U.S. Securities and Exchange Commission are Philip Haydon, the chairman of neuroscience at Tufts University, and Michael Szulczewski, the CEO of microscope maker Prairie Technologies. The startup, located ... |
Show more
Reviews 0
FAQ about Treatment
What has the press written about Treatment?
Parsers VC has collected 20 articles mentioning Treatment, among them “PRESS RELEASE | ADEQ Announces $25 Million Investment to Improve PFAS Treatment at Tucson Water Treatment Plant” (Dec 23, 2022) and “American Treatment Network Raises $5.3 Million in Oversubscribed Series A” (Sep 2, 2021).
Is Treatment still active?
Yes, Treatment is active; its latest activity on Parsers VC dates from Jan 12, 2023.